Related Experiment Videos
Editor's Note: Pathophysiology of the Basal Ganglia Grows in Understanding and Complexity but Essential Unknown
Jose A Obeso1,2,3
1HM CINAC, Puerta del Sur, Mostoles, Madrid, Spain.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Divergent tau pathology profiles induced by distinct alpha-synuclein aggregates in non-human primates.
Brain : a journal of neurology·2026
MRI mapping of nigrostriatal pathway degeneration in early-stage Parkinson's disease.
Neurobiology of disease·2026
Taurine and MAO B binding sites in the brain of monkeys determine differing responses to MPTP administration.
Journal of neuroscience methods·2026
Noninvasive Focal Gene Delivery into the Cerebellum of Non-Human Primates using Focused Ultrasound.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3.
Movement disorders : official journal of the Movement Disorder Society·2026
A De Novo 16p13.3 Triplication Underlying Early-Onset Complex Neurodegeneration.
Movement disorders : official journal of the Movement Disorder Society·2026
Novel and Emerging Therapies for Childhood-Onset Movement Disorders.
Movement disorders : official journal of the Movement Disorder Society·2026
Selectivity Filter KCND3 Variant Causes Spinocerebellar Ataxia 19/22 and KV4.3 Functional Loss.
Movement disorders : official journal of the Movement Disorder Society·2026
Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society·2026
Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.
Movement disorders : official journal of the Movement Disorder Society·2026
NG2-Glia in Central Nervous System Following Injury: From Pathological Involvement to Repair Potential.
CNS neuroscience & therapeutics·2026